Graves Disease

"Graves Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Descriptor ID	D006111
MeSH Number(s)	C11.675.349.500 C19.874.283.605 C19.874.397.370 C20.111.555
Concept/Terms	Graves Disease Graves Disease Disease, Graves Basedow Disease Disease, Basedow Graves' Disease Disease, Graves' Exophthalmic Goiter Exophthalmic Goiters Goiters, Exophthalmic Goiter, Exophthalmic Hyperthyroidism, Autoimmune Basedow's Disease Basedows Disease Disease, Basedow's

Below are MeSH descriptors whose meaning is more general than "Graves Disease".

Diseases [C]
Eye Diseases [C11]
Orbital Diseases [C11.675]
Exophthalmos [C11.675.349]
Graves Disease [C11.675.349.500]
Endocrine System Diseases [C19]
Thyroid Diseases [C19.874]
Goiter [C19.874.283]
Graves Disease [C19.874.283.605]
Hyperthyroidism [C19.874.397]
Graves Disease [C19.874.397.370]
Immune System Diseases [C20]
Autoimmune Diseases [C20.111]
Graves Disease [C20.111.555]

Below are MeSH descriptors whose meaning is related to "Graves Disease".

Below are MeSH descriptors whose meaning is more specific than "Graves Disease".

Graves Disease
Graves Ophthalmopathy

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Graves Disease" by people in this website by year, and whether "Graves Disease" was a major or minor topic of these publications.

Bar chart showing 12 publications over 10 distinct years, with a maximum of 2 publications in 2010 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
2001	1	0	1
2006	1	0	1
2009	1	0	1
2010	1	1	2
2011	1	0	1
2013	0	1	1
2016	1	0	1
2017	1	0	1
2022	2	0	2

Below are the most recent publications written about "Graves Disease" by people in Profiles.

Cho YY, Kim B, Choi D, Kim CH, Shin DW, Kim JS, Park SJ, Kim SW, Chung JH, Han K, Kim TH. Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study. Front Endocrinol (Lausanne). 2022; 13:1032764.

View in: PubMed
Graves CE, Campbell MJ. Best Left to the Experts: Proficiency and Experience are Key for Safety in Remote-Access Thyroidectomy for Graves' Disease. World J Surg. 2022 05; 46(5):1114-1115.

View in: PubMed
Creo AL, Candela N, Lee MM, Feldman PM. An Unusual Manifestation of Celiac Disease in an Adolescent With Down Syndrome and Graves Disease. J Pediatr Gastroenterol Nutr. 2017 07; 65(1):e20-e22.

View in: PubMed
Lee HJ, Lombardi A, Stefan M, Li CW, Inabnet WB, Owen RP, Concepcion E, Tomer Y. CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor ?B Activation. Endocrinology. 2017 02 01; 158(2):410-418.

View in: PubMed
Whalen G, Sullivan M, Maranda L, Quinlan R, Larkin A. Randomized trial of a short course of preoperative potassium iodide in patients undergoing thyroidectomy for Graves' disease. Am J Surg. 2017 Apr; 213(4):805-809.

View in: PubMed
Chhabra L, Khalid N, Spodick DH. [Letter on the article "Pericardial effusion: an unknown expression of Graves' disease"]. Presse Med. 2014 Dec; 43(12 Pt 1):1407.

View in: PubMed
Chhabra L, Spodick DH. A comment on thyrotoxic pericarditis. Int J Cardiol. 2014 May 15; 173(3):587.

View in: PubMed
Borodic GE, Hinkle D. Ipilimumab-induced orbital inflammation resembling Graves disease with subsequent development of systemic hyperthyroidism from CTLA-4 receptor suppression. Ophthalmic Plast Reconstr Surg. 2014 Jan-Feb; 30(1):83.

View in: PubMed
Campbell MJ, McCoy KL, Shen WT, Carty SE, Lubitz CC, Moalem J, Nehs M, Holm T, Greenblatt DY, Press D, Feng X, Siperstein AE, Mitmaker E, Benay C, Tabah R, Oltmann SC, Chen H, Sippel RS, Brekke A, Vriens MR, Lodewijk L, Stephen AE, Nagar S, Angelos P, Ghanem M, Prescott JD, Zeiger MA, Aragon Han P, Sturgeon C, Elaraj DM, Nixon IJ, Patel SG, Bayles SW, Heneghan R, Ochieng P, Guerrero MA, Ruan DT. A multi-institutional international study of risk factors for hematoma after thyroidectomy. Surgery. 2013 Dec; 154(6):1283-89; discussion 1289-91.

View in: PubMed
Merrill S, Horowitz J, Traino AC, Chipkin SR, Hollot CV, Chait Y. Accuracy and optimal timing of activity measurements in estimating the absorbed dose of radioiodine in the treatment of Graves' disease. Phys Med Biol. 2011 Feb 07; 56(3):557-71.

View in: PubMed

People

Explore

Similar Concepts

Top Journals